NCT06604871View on ClinicalTrials.gov

Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

September 26, 2025

Study Completion Date

September 26, 2025

Conditions
Type 1 Diabetes
Interventions
DEVICE

Insulin Pump with Continuous Glucose Monitoring

MiniMed™ 780G insulin pump in combination with the DS5 CGM

Trial Locations (8)

32207

Nemours Childrens Specialty Care, Jacksonville

33612

USF Diabetes and Endocrinology Center, Tampa

44106

University Hospitals Cleveland Medical Center, Cleveland

77030

Texas Childrens Hospital, Houston

80045

Barbara Davis Center for Childhood Diabetes, Aurora

94158

UCSF The Madison Clinic for Pediatric Diabetes, San Francisco

94304

Stanford University, Palo Alto

06511

Yale School of Medicine, New Haven

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT06604871 - Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children | Biotech Hunter | Biotech Hunter